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Abstract
Background: Many people now seek alternative methods of weight loss. The internet provides a
readily available source of weight reduction products, the ingredients of which are often unclear.
The authors describe a case of acute hepatitis in a 20 year old woman caused by such a product
purchased over the internet.
Case Presentation: A 20-year old woman presented with a two day history of abdominal pain,
vomiting and jaundice. There were no identifiable risk factors for chronic liver disease. Liver
function tests demonstrated an acute hepatitis (aminoaspartate transaminase 1230 IU/L). A chronic
liver disease screen was negative. The patient had started a weight loss product (Pro-Lean),
purchased over the internet two weeks prior to presentation. The patient was treated
conservatively, and improved. The sequence of events suggests an acute hepatitis caused by an
herbal weight loss product.
Conclusion: This case report highlights the dangers of weight loss products available to the public
over the internet, and the importance of asking specifically about alternative medicines in patients
who present with an acute hepatitis.
Background
Obesity is increasingly recognised as a medical problem
[1]. Many people now seek alternative methods of weight
loss, in particular weight reduction products, some of
which are available over the internet. The potential dan-
gers of these products are often not known. The authors
describe a case of acute hepatitis in a 20 year old woman
caused by such a product purchased over the internet.
Case Presentation
A 20-year-old woman presented with a two-day history of
right upper quadrant pain, vomiting and jaundice. She
did not drink alcohol and her only regular medication
was the oral contraceptive pill that she had taken for many
years. There was no history of recent foreign travel. There
had also been no recent use of paracetamol, non steroidal
anti-inflammatory drugs (NSAIDs), anti-biotics, or recre-
ational drugs. She denied the use of intravenous drugs.
On examination, she was icteric, with epigastric tender-
ness but no palpable organomegaly. There was no hepatic
encephalopathy, nor stigmata of chronic liver disease. The
full blood count was normal; white cell count 7.4 109/L
(NR 4–11), platelets 200 109/L (NR 150–400), haemo-
globin 15.9 g/dl (NR 11–13). Urea and electrolytes and
coagulation studies were also normal. Liver functions tests
(LFTs) were abnormal; bilirubin 53 µmol/L (1–19), alka-
line phosphatase 92 IU/L (ALP 25–100), aspartate ami-
notransaminase 1230 IU/L (AST 7–40), albumin 40 g/L
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(36–52), and international normalised ratio 1.1 (INR
0.8–1.3). Hepatitis A IgM (HAV IgM), hepatitis B surface
antigen (HBsAg) and hepatitis C antibody (HCV Ab) were
negative. Herpes simplex virus, Epstein Barr virus and
cytomegalovirus were all undetectable. Auto-immune
antibody serology, serum copper, caeruloplasmin, and
ferritin were normal. Hepato-biliary ultrasonography was
normal. On further questioning, the patient volunteered
that she had started a weight-loss product called, Pro-lean,
two weeks before admission. This had been purchased
over the internet. Pro-lean was stopped, and the LFTs
started to improve. On discharge (5 days later) her LFTs
continued to improve (see Table 1). A liver biopsy was not
performed, because of the rapid biochemical improve-
ment. At two-months from the initial presentation the
LFTs had normalised (Table 1), and the patient remained
well. Repeat virology (HAV IgM, HBsAg and HCV Ab), in
the convalescent stage remained negative.
Discussion
Two-thirds of adults over 45 years are now classified as
being obese. Obesity was estimated to have cost the NHS
£500,000,000 in 1998. As levels have risen, so to have the
number of diets and treatments alternative to the tradi-
tional methods of weight loss.
Pro-Lean, by Pro-image is a weight loss product contain-
ing herbs, botanicals and chromium. One capsule (to be
taken once per day) contains 150 µg of chromium (chro-
mium dinicotinate glycinate), 12–15 µg of vitamin B12,
50 µg of vanadium, caffeine 200 mg, 150 µg of cyperus
root extract and 50 µg of L-tyrosine. Furthermore, other
ingredients include ma-huang, guarana, kola nut, white
willow bark, ginkgo biloba, bladderwrack, gotu kola,
boron, ginseng, fo-ti, magnesium salicylate, folic acid, bee
pollen, spirulina and ginger root. Chromium toxicity has
been linked with cases of hepatic, renal and cardiac fail-
ure, as well as bronchial malignancy [2]. The daily
requirement is 5 to 115 µg/day. Chromium-induced toxic
hepatitis has previously been described, in a 35-year old
woman who had been taking a chromium dietary product
(200 µg/day) for five months [3]. However, it is often dif-
ficult to determine which component of these products is
responsible for hepato-toxicity as there are often many
pharmacologically active constituents. Many herbal prod-
ucts have been implicated in liver toxicity including kava,
chapparal, germander, comfrey roots [4], and also ma
huang [5]. Orthotopic liver transplantation has been
required in some cases of drug induced hepatitis caused
by herbal remedies observed [6]. In the United Kingdom
health products are treated as food if they are not granted
a medical license. No health claims can be made on the
labelling. In the United States food, and drug administra-
tion (FDA) approval is only needed for medicines. Herbal
products do not fall into this category and are viewed as
dietary supplements. Patients may regard these products
as healthy alternatives and may be unaware of their side
effects, and contents. An analysis of 260 Asian patent
medicines studied by the Californian health services, food
and drug branch found that 32% of the analysed samples
contained undeclared pharmaceuticals and heavy metals
[7].
On discontinuation of Pro-Lean the patient improved
both clinically and bio-chemically, suggesting causality.
The clinical diagnostic scale (CDS) is a useful screening
tool which has been developed for the diagnosis of drug
induced liver injury [8]. The CDS score in this case was 12.
A CDS score of >9 is assumed to be drug related unless an
alternative diagnosis is suspected. It is difficult to ascribe
the observed hepatic toxicity to one specific ingredient
alone contained within Pro-Lean. Chromium toxicity
would be less likely given the normal renal function. The
clinical presentation and pattern of hepatic toxicity in this
case is very similar to the case described by Nadir et al
(1996), suggesting ma huang may have played an active
role.
Conclusion
This case highlights the importance of inquiring into alter-
native medicines, herbal remedies and unconventional
diets in cases of acute hepatitis, where the cause is uncer-
tain. It also raises questions regarding the regulation,
licensing and safety of herbal and alternative health prod-
ucts that can be bought over the internet.
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Table 1: Progression of liver function tests.
Admission Discharge 2 months post 
discharge
Bilirubin µmol/L 
(1–19)
53 42 8
ALP IU/L 
(25–100)
92 101 35
AST IU/L (7–40) 1230 286 28
Albumin g/L 
(36–52)
40 38 38
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